Clinical Trials Insight: 700040556
Phase of Trial: Phase II
Latest Information Update: 16 Jan 2009
At a glance
- Drugs Irinotecan (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- Sponsors Nektar Therapeutics
- 16 Jan 2009 New trial record.
- 13 Jan 2009 Institutional Review Board approval received, according to a Nektar Therapeutics media release.